Skip to main content
. 2023 Aug 29;106(4):369–376. doi: 10.1308/rcsann.2022.0140

Table 1 .

Univariate analysis of factors associated with peritoneal metastases for all oesophagogastric cancer patients

No metastases (n = 872) Metastases (n = 96) p-value
Age, median (IQR) 68 (60–74) 69 (60–77) 0.408
Male 550 (63) 57 (59) 0.768
Cancer site <0.001
 Oesophageal 280 (97) 8 (3)
 GOJ 367 (93) 29 (7)
 Gastric 225 (79) 59 (21)
OGD histology 0.339
 Adenocarcinoma 663 (91) 63 (9)
 Squamous cell qcarcinoma 57 (97) 2 (3)
 Other 65 (90) 7 (10)
EUS T stage 0.462
 T1–2 97 (25) 2 (25)
 T3 278 (71) 5 (63)
 T4 15 (4) 1 (13)
EUS N stage 0.732
 N0 163 (43) 2 (29)
 N1 194 (51) 5 (71)
 N2 18 (5) 0 (0)
 N3 4 (1) 0 (0)
CT T stage <0.001
 T1 12 (100) 0 (0)
 T2 133 (98) 3 (2)
 T3 574 (90) 61 (10)
 T4 44 (71) 18 (29)
CT N stage 0.029
 N0 400 (92) 34 (8)
 N1 322 (91) 33 (9)
 N2 85 (89) 11 (12)
 N3 13 (72) 5 (28)
PET 0.534
 M0 579 (97) 26 (96)
 M1 16 (3) 1 (4)

Values are given as n (%), unless noted otherwise.

CT = computed tomography; EUS = endoscopic ultrasound; GOJ = gastro-oesophageal junction; IQR = interquartile range; OGD = oesophagogastroduodenoscopy; PET = positron emission tomography